ChartRow logo
Data provided bySource: Twelve Data
ARWR
$42.99-2.76%
as of close, Nov 17, 2026
☾ AH $42.99 -2.76%
PeersROIVAXSMCYTKIBRXSPYQQQ
Share this page

Arrowhead Pharmaceuticals Inc. monthly returns

Arrowhead Pharmaceuticals Inc. has averaged 4.81% a month with dividends reinvested, and risen in 43% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.

Average month
+4.8%
395 months
Best month
+438.5%
Jan 2004
Worst month
-86.0%
Dec 1994
Positive months
43%
of all months
Arrowhead Pharmaceuticals Inc. total return by month
MonthTotal return
Nov 2026
-28.2%
Oct 2026
-8.5%
Sep 2026
-20.6%
Aug 2026
-2.7%
Jul 2026
+3.9%
Jun 2026
+4.6%
May 2026
+6.0%
Apr 2026
+17.2%
Mar 2026
-0.9%
Feb 2026
-8.7%
Jan 2026
+4.4%
Dec 2025
+26.0%
Nov 2025
+24.3%
Oct 2025
+22.9%
Sep 2025
+56.6%
Aug 2025
+39.4%
Jul 2025
+0.0%
Jun 2025
-1.7%
May 2025
+15.7%
Apr 2025
+9.0%
Mar 2025
-32.6%
Feb 2025
-4.9%
Jan 2025
+5.7%
Dec 2024
-27.8%
Nov 2024
+35.4%
Oct 2024
-0.7%
Sep 2024
-18.7%
Aug 2024
-16.6%
Jul 2024
+9.9%
Jun 2024
+13.2%
May 2024
+1.5%
Apr 2024
-20.9%
Mar 2024
-10.9%
Feb 2024
+0.0%
Jan 2024
+4.9%
Dec 2023
+44.3%
Nov 2023
-13.8%
Oct 2023
-8.5%
Sep 2023
-2.8%
Aug 2023
-19.9%
Jul 2023
-3.2%
Jun 2023
+3.6%
May 2023
-2.8%
Apr 2023
+39.4%
Mar 2023
-21.4%
Feb 2023
-7.7%
Jan 2023
-13.7%
Dec 2022
+26.0%
Nov 2022
-7.5%
Oct 2022
+5.3%
Sep 2022
-16.8%
Aug 2022
-6.6%
Jul 2022
+20.8%
Jun 2022
+5.5%
May 2022
-18.9%
Apr 2022
-10.6%
Mar 2022
+4.5%
Feb 2022
-16.6%
Jan 2022
-20.4%
Dec 2021
-5.4%
Nov 2021
+9.8%
Oct 2021
+2.2%
Sep 2021
-7.0%
Aug 2021
-3.1%
Jul 2021
-16.3%
Jun 2021
+14.1%
May 2021
-0.2%
Apr 2021
+9.7%
Mar 2021
-16.8%
Feb 2021
+3.2%
Jan 2021
+0.6%
Dec 2020
+22.7%
Nov 2020
+9.1%
Oct 2020
+33.1%
Sep 2020
+1.9%
Aug 2020
-1.9%
Jul 2020
-0.3%
Jun 2020
+34.0%
May 2020
-6.4%
Apr 2020
+19.7%
Mar 2020
-18.6%
Feb 2020
-15.6%
Jan 2020
-33.9%
Dec 2019
-13.1%
Nov 2019
+82.3%
Oct 2019
+42.1%
Sep 2019
-17.5%
Aug 2019
+17.6%
Jul 2019
+9.7%
Jun 2019
+11.8%
May 2019
+31.9%
Apr 2019
-2.0%
Mar 2019
-6.0%
Feb 2019
+38.2%
Jan 2019
+13.7%
Dec 2018
-14.5%
Nov 2018
+14.2%
Oct 2018
-33.6%
Sep 2018
+29.9%
Aug 2018
+1.3%
Jul 2018
+7.1%
Jun 2018
+26.9%
May 2018
+67.0%
Apr 2018
-11.0%
Mar 2018
+11.3%
Feb 2018
+4.9%
Jan 2018
+67.9%
Dec 2017
+3.1%
Nov 2017
-1.9%
Oct 2017
-15.9%
Sep 2017
+54.6%
Aug 2017
+59.1%
Jul 2017
+8.6%
Jun 2017
+12.5%
May 2017
-7.1%
Apr 2017
-16.2%
Mar 2017
-18.1%
Feb 2017
+16.5%
Jan 2017
+25.2%
Dec 2016
+7.6%

Monthly total return (since Dec 2021)#

Arrowhead Pharmaceuticals Inc. returns by calendar month#

Every month of every year since 1994, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.

November 2026 so far: -28.23% — 29th of 33 Novembers since 1994 at the last close; the average November returned +5.0%.

Arrowhead Pharmaceuticals Inc. returns by calendar month since 1994
Month−440%0+440%AverageUp
Jan+30.2%52%
Feb-6.2%36%
Mar+9.6%48%
Apr+6.6%42%
May+1.4%36%
Jun+0.1%48%
Jul+1.6%52%
Aug+4.0%36%
Sep+7.1%48%
Oct-7.1%33%
NovNovember 2026 so far: -28.2%+5.0%47%
Dec+6.5%41%

Methodology#

Monthly returns are total returns (dividends reinvested), computed from ARWR's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.

FAQ#

What is Arrowhead Pharmaceuticals Inc.'s average monthly return?
Arrowhead Pharmaceuticals Inc. has averaged about 4.81% per month (dividends reinvested), positive in roughly 43% of months. The best month was Jan 2004 (+438.5%) and the worst was Dec 1994 (-86.0%).

More on Arrowhead Pharmaceuticals Inc.